Skip to content

SCHEDULE 13GAccepted Jun 18, 4:29 PM ET

Avalo Therapeutics, Inc. SCHEDULE 13G

Commodore Capital LP

Accepted (ET)

4:29 PM

Jun 18, 2026

Filed

Jun 18, 2026

Documents

2

Size

16.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.